These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2963570)

  • 1. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine.
    Horowitz MM; Ershler WB; McKinney WP; Battiola RJ
    Ann Intern Med; 1988 Feb; 108(2):185-9. PubMed ID: 2963570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of response to intramuscular versus low dose intradermal hepatitis B booster immunization.
    McKinney WP; Russler SK; Horowitz MM; Battiola RJ; Lee MB
    Infect Control Hosp Epidemiol; 1991 Apr; 12(4):226-30. PubMed ID: 1829469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of antibody to hepatitis B surface antigen after low-dose, intradermal hepatitis B immunization and response to a booster dose.
    Bryan JP; Sjogren MH; Macarthy P; Cox E; Legters LJ; Perine PL
    Vaccine; 1992; 10(1):33-8. PubMed ID: 1531719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel--a preliminary report.
    Prasetya E; Linggadjaja W; Syambali R; Kusumo S; Dharmesetyawan DF; Rahardja U
    Ann Acad Med Singap; 1986 Apr; 15(2):153-7. PubMed ID: 2944466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly.
    King JW; Taylor EM; Crow SD; White MC; Todd JR; Poe MB; Conrad SA; Gelder FB
    Rev Infect Dis; 1990; 12(6):1035-43. PubMed ID: 2148433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of intradermal hepatitis B immunization of hospital staff.
    McKee CM; Duke P; McEvoy MB; Kelsey MC
    Int J STD AIDS; 1990 Jan; 1(1):32-4. PubMed ID: 2151564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal hepatitis B vaccination in a 300-bed primary care hospital: experience with a recombinant vaccine in a four-dose schedule.
    McMaster KR; Roper JK; Carter JB
    Am J Infect Control; 1993 Dec; 21(6):283-8. PubMed ID: 8122799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine.
    Parish DC; Muecke HW; Joiner TA; Pope WT; Hadler SC
    South Med J; 1991 Apr; 84(4):426-30. PubMed ID: 1826567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes.
    Heijtink RA; Knol RM; Schalm SW
    J Med Virol; 1989 Feb; 27(2):151-4. PubMed ID: 2522147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A; Moyes CD; Dimitrakakis M
    N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine.
    Lancaster D; Elam S; Kaiser AB
    Am J Infect Control; 1989 Jun; 17(3):126-9. PubMed ID: 2742197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal and intramuscular route for vaccination against hepatitis B.
    González ML; Usandizaga M; Alomar P; Salvá F; Martín F; Erroz MJ; Lardinois R
    Vaccine; 1990 Aug; 8(4):402-5. PubMed ID: 2144391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results.
    Ayoola EA; Atoba MA; Johnson AO
    Arch Virol; 1986; 91(3-4):291-6. PubMed ID: 2946277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
    Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
    JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.
    Mok Q; Underhill G; Wonke B; Aldouri M; Kelsey M; Jefferies D
    Arch Dis Child; 1989 Apr; 64(4):535-40. PubMed ID: 2526622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age.
    Morris CA; Oliver PR; Reynolds F; Selkon JB
    Epidemiol Infect; 1989 Oct; 103(2):387-94. PubMed ID: 2530104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.